Posts by Sandra Ansanay-Alex
Debiopharm lays the foundation stone for its new building
The new building will have a surface area of 3,500m2 dedicated to the creation of 150 to 300 flexible workstations. It will enable the company to expand and develop. The work will be completed in 2026. The building will also house a reservoir containing a total of 4.5 million litres of water, which…
Read MoreLatsis Prize: Prof. Mackenzie W. Mathis Awarded
Mackenzie W. Mathis, a professor at EPFL and winner of the Latsis 2024 Swiss Science Prize, is a pioneer in the application of artificial intelligence (AI) to behavioural neuroscience. Prof. Mathis research aims to understand the neural bases of learning and movement. She uses mice playing video games while recording their brain activity,…
Read MoreE-health: The Sense and ZS join forces
The Sense, a Swiss-based academic research and innovation centre, is teaming up with ZS, an international firm renowned for its expertise in healthcare, analytics, technology and research, to revolutionise clinical research and e-health. Their collaboration will focus on validating digital devices and therapies for regulatory approval, as well as conducting real-life studies to…
Read MoreVenture Leaders Medtech: Meet the 2024 Swiss Team
10 promising startups were selected by Venture Leaders Medtech. 3 of them are from the Swiss Health Valley. They will travel to Boston from 4 to 8 November as part of the Swiss National Startup Team where they will meet investors. Apersys (ZH): Overcomes organ shortage with an advanced perfusion system. Metadvice (VD): …
Read MoreTOP 100 Swiss Startup Award 2024
This year, 15 startups from the Swiss Health Valley we ranked in the prestigious TOP 100 Swiss Startup Award 2024, including HAYA Therapeutics at #5. The 14th ceremony of the TOP 100 Swiss Startup Award took place in Lausanne and was attended by a curated audience comprising startup founders, investors, and key partners…
Read MoreHAYA Therapeutics Announces $1 billion Collaboration with Lilly
The Biopôle-based biotech company and the American pharma giant partner to discover novel regulatory genome targets for obesity and related metabolic conditions using HAYA Therapeutics proprietary RNA platform HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for chronic diseases, announced a multi-year agreement with Eli Lilly and Company to apply…
Read MoreLife Sciences account for 10% of the canton of Fribourg economy
According to a BAK Economy study, life sciences generated added value of over CHF 1.5 billion in 2023 and employed 3,300 full-time equivalents (FTEs). Through value chains, numerous companies in other economic sectors also benefit from the activities of the life sciences industry. Thus, a total added value of 1.96 billion francs, representing 10% of…
Read MoreSFNV Forum: Precision Nutrition
Swiss Food and Nutrition Impact Forums are one-hour online seminars featuring Swiss and international experts. The 21 October 2024 event is about Precision Nutrition. Precision Nutrition is an emerging area of research that focuses on the relationship between genes and other individual-specific information, nutrition and health. We know that we need to move…
Read MorePlair brings its Rapid-C+ on the market
Rapid-C+, an advanced real-time air microbial detector that sets new standards in environmental monitoring, is now on the market. The device was designed by Plair, a Geneva-based startup. Rapid-C+ uses patented biofluorescent particle counting technology to detect and identify viable contaminants in real time. Its state-of-the-art features include laser-based light scattering and fluorescence…
Read MoreThe Swiss Institute of Bioinformatics has launches the Centre for Pathogen Bioinformatics
The Centre aims to enhance Switzerland’s role in global pathogen bioinformatics research, providing expertise and services to federal authorities and the international research community. This will support pandemic preparedness and real-time pathogen surveillance. The Centre will contribute to the pathogen response and public health strategies at both national and international scale. It will…
Read More